ABSTRACT
A major clinical challenge today is the large number of bone defects caused by diseases or trauma. The development of three-dimensional (3D) scaffolds with adequate properties is crucial for successful bone repair. In this study, we prepared biomimetic mesoporous bioactive glass (MBG)-based scaffolds with and without ceria addition (up to 3 mol %) to explore the biological structure and chemical composition of the marine sponge Spongia Agaricina (SA) as a sacrificial template. Micro-CT examination revealed that all scaffolds exhibited a highly porous structure with pore diameters primarily ranging from 143.5 µm to 213.5 µm, facilitating bone ingrowth. Additionally, smaller pores (< 75 µm), which are known to enhance osteogenesis, were observed. The undoped scaffold displayed the highest open porosity value of 90.83%. Cytotoxicity assessments demonstrated that all scaffolds were noncytotoxic and nongenotoxic toward osteoblast cells. Moreover, scaffolds with higher CeO2 content promoted osteogenic differentiation of dental pulp stem cells, stimulating calcium and osteocalcin secretion. The scaffolds also exhibited antimicrobial and antibiofilm effects against Staphylococcus aureus (S. aureus) as well as drug delivery ability. Our research findings indicated that the combination of MBG, natural biological structure, and the addition of Ce exhibited a synergistic effect on the structure and biological properties of scaffolds for applications in bone tissue engineering.
Subject(s)
Anti-Infective Agents , Osteogenesis , Tissue Scaffolds/chemistry , Staphylococcus aureus , Bone Regeneration , Tissue Engineering/methods , Porosity , Glass/chemistryABSTRACT
The excess of free radicals causes numerous imbalances in the body that lead to premature aging, the degradation of internal structures, and the appearance of numerous pathologies responsible for the increased risk of premature death. The present work aims to evaluate the physical, chemical, pharmacotechnical, and antioxidant activity of newly achieved capsule formulations. These two formulations were F1a.i., which contains melatonin:biotin:coenzyme Q10 (weight ratio of 1:2:60), and F2a.i., which contains quercetin:resveratrol:biotin:coenzyme Q10 (weight ratio of 10:10:1:10). The adequate selection of the excipient types and amounts for final capsule formulations (F1c.c., F2c.c.) was based on preformulation studies performed on the powders containing active ingredients. The antioxidant activity assessed using three methods (ABTS, DPPH, and FRAP) compared with acid ascorbic as a positive control demonstrated that the F2c.c. formulation possesses the strongest antioxidant capacity. The results confirmed the suitable formulation and the accurate selection of the types and amounts of active ingredients, as well as the auxiliary excipients used in newly developed capsule formulations as supplements with an excellent antioxidant effect on the human body.
Subject(s)
Antioxidants , Biotin , Humans , Antioxidants/metabolism , Resveratrol , Dietary Supplements , Quercetin , Excipients/chemistryABSTRACT
Knowledge of the crystallization stability of bioactive glasses (BGs) is a key factor in developing porous scaffolds for hard tissue engineering. Thus, the crystallization behavior of three mesoporous bioactive glasses (MBGs) in the 70SiO2-(26-x)CaO-4P2O5-xCeO2 system (x stands for 0, 1 and 5 mol. %, namely MBG(0/1/5)Ce), prepared using the sol-gel method coupled with the evaporation-induced self-assembly method (EISA), was studied. A thermal analysis of the multiple-component crystallization exotherms from the DSC scans was performed using the Kissinger method. The main crystalline phases of Ca5(PO4)2.823(CO3)0.22O, CaSiO3 and CeO2 were confirmed to be generated by the devitrification of the MBG with 5% CeO2, MBG5Ce. Increasing the ceria content triggered a reduction in the first crystallization temperature while ceria segregation took place. The amount of segregated ceria of the annealed MBG5Ce decreased as the annealing temperature increased. The optimum processing temperature range to avoid the crystallization of the MBG(0/1/5)Ce powders was established.
ABSTRACT
In recent years, the rising number of bone diseases which affect millions of people worldwide has led to an increased demand for materials with restoring and augmentation properties that can be used in therapies for bone pathologies. In this work, PMMA- MBG composite scaffolds containing ceria (0, 1, 3 mol%) were obtained by the phase separation method. The obtained composite scaffolds were characterized by X-ray diffraction, infrared spectroscopy, and scanning electron microscopy. UV-Vis measurement and EDX analysis confirmed the presence of cerium ions in the composite scaffolds. Evaluation of the in-vitro biocompatibility using MTT assay showed that composite scaffold containing 1 mol% of ceria presented higher viability than control cells (100%) for concentrations ranging between 5 and 50% after 96 h of incubation.